Global Recombinant Factor Products Supply, Demand and Key Producers, 2024-2030

March 2024 | 129 pages | ID: G656CFA39585EN
GlobalInfoResearch

Abstracts

The global Recombinant Factor Products market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Recombinant Factor Products demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Factor Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Factor Products that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Recombinant Factor Products total market, 2019-2030, (USD Million)

Global Recombinant Factor Products total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Recombinant Factor Products total market, key domestic companies and share, (USD Million)

Global Recombinant Factor Products revenue by player and market share 2019-2024, (USD Million)

Global Recombinant Factor Products total market by Type, CAGR, 2019-2030, (USD Million)

Global Recombinant Factor Products total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Recombinant Factor Products market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Novartis, Baxter, Britannia, Capricor, CSL Behring, GlaxoSmithKline, Grifol and Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Factor Products market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Recombinant Factor Products Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Recombinant Factor Products Market, Segmentation by Type

• Clotting Factor I
• Clotting Factor II
• Clotting Factor III
• Clotting Factor IV
• Others

Global Recombinant Factor Products Market, Segmentation by Application

• Hospitals
• Clinics

Companies Profiled:

• Amgen
• Novartis
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifol
• Eli Lilly
• Bayer
• Pfizer

Key Questions Answered

1. How big is the global Recombinant Factor Products market?

2. What is the demand of the global Recombinant Factor Products market?

3. What is the year over year growth of the global Recombinant Factor Products market?

4. What is the total value of the global Recombinant Factor Products market?

5. Who are the major players in the global Recombinant Factor Products market?

Contents

1 SUPPLY SUMMARY

1.1 Recombinant Factor Products Introduction
1.2 World Recombinant Factor Products Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Recombinant Factor Products Total Market by Region (by Headquarter Location)
  1.3.1 World Recombinant Factor Products Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States Recombinant Factor Products Market Size (2019-2030)
  1.3.3 China Recombinant Factor Products Market Size (2019-2030)
  1.3.4 Europe Recombinant Factor Products Market Size (2019-2030)
  1.3.5 Japan Recombinant Factor Products Market Size (2019-2030)
  1.3.6 South Korea Recombinant Factor Products Market Size (2019-2030)
  1.3.7 ASEAN Recombinant Factor Products Market Size (2019-2030)
  1.3.8 India Recombinant Factor Products Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Recombinant Factor Products Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Recombinant Factor Products Major Market Trends

2 DEMAND SUMMARY

2.1 World Recombinant Factor Products Consumption Value (2019-2030)
2.2 World Recombinant Factor Products Consumption Value by Region
  2.2.1 World Recombinant Factor Products Consumption Value by Region (2019-2024)
  2.2.2 World Recombinant Factor Products Consumption Value Forecast by Region (2025-2030)
2.3 United States Recombinant Factor Products Consumption Value (2019-2030)
2.4 China Recombinant Factor Products Consumption Value (2019-2030)
2.5 Europe Recombinant Factor Products Consumption Value (2019-2030)
2.6 Japan Recombinant Factor Products Consumption Value (2019-2030)
2.7 South Korea Recombinant Factor Products Consumption Value (2019-2030)
2.8 ASEAN Recombinant Factor Products Consumption Value (2019-2030)
2.9 India Recombinant Factor Products Consumption Value (2019-2030)

3 WORLD RECOMBINANT FACTOR PRODUCTS COMPANIES COMPETITIVE ANALYSIS

3.1 World Recombinant Factor Products Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Recombinant Factor Products Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Recombinant Factor Products in 2023
  3.2.3 Global Concentration Ratios (CR8) for Recombinant Factor Products in 2023
3.3 Recombinant Factor Products Company Evaluation Quadrant
3.4 Recombinant Factor Products Market: Overall Company Footprint Analysis
  3.4.1 Recombinant Factor Products Market: Region Footprint
  3.4.2 Recombinant Factor Products Market: Company Product Type Footprint
  3.4.3 Recombinant Factor Products Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Recombinant Factor Products Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Recombinant Factor Products Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: Recombinant Factor Products Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Recombinant Factor Products Consumption Value Comparison
  4.2.1 United States VS China: Recombinant Factor Products Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Recombinant Factor Products Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Recombinant Factor Products Companies and Market Share, 2019-2024
  4.3.1 United States Based Recombinant Factor Products Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Recombinant Factor Products Revenue, (2019-2024)
4.4 China Based Companies Recombinant Factor Products Revenue and Market Share, 2019-2024
  4.4.1 China Based Recombinant Factor Products Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Recombinant Factor Products Revenue, (2019-2024)
4.5 Rest of World Based Recombinant Factor Products Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based Recombinant Factor Products Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Recombinant Factor Products Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Recombinant Factor Products Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Clotting Factor I
  5.2.2 Clotting Factor II
  5.2.3 Clotting Factor III
  5.2.4 Clotting Factor IV
  5.2.5 Others
5.3 Market Segment by Type
  5.3.1 World Recombinant Factor Products Market Size by Type (2019-2024)
  5.3.2 World Recombinant Factor Products Market Size by Type (2025-2030)
  5.3.3 World Recombinant Factor Products Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Recombinant Factor Products Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Clinics
6.3 Market Segment by Application
  6.3.1 World Recombinant Factor Products Market Size by Application (2019-2024)
  6.3.2 World Recombinant Factor Products Market Size by Application (2025-2030)
  6.3.3 World Recombinant Factor Products Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Amgen
  7.1.1 Amgen Details
  7.1.2 Amgen Major Business
  7.1.3 Amgen Recombinant Factor Products Product and Services
  7.1.4 Amgen Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Amgen Recent Developments/Updates
  7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Novartis
  7.2.1 Novartis Details
  7.2.2 Novartis Major Business
  7.2.3 Novartis Recombinant Factor Products Product and Services
  7.2.4 Novartis Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Novartis Recent Developments/Updates
  7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Baxter
  7.3.1 Baxter Details
  7.3.2 Baxter Major Business
  7.3.3 Baxter Recombinant Factor Products Product and Services
  7.3.4 Baxter Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Baxter Recent Developments/Updates
  7.3.6 Baxter Competitive Strengths & Weaknesses
7.4 Britannia
  7.4.1 Britannia Details
  7.4.2 Britannia Major Business
  7.4.3 Britannia Recombinant Factor Products Product and Services
  7.4.4 Britannia Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 Britannia Recent Developments/Updates
  7.4.6 Britannia Competitive Strengths & Weaknesses
7.5 Capricor
  7.5.1 Capricor Details
  7.5.2 Capricor Major Business
  7.5.3 Capricor Recombinant Factor Products Product and Services
  7.5.4 Capricor Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Capricor Recent Developments/Updates
  7.5.6 Capricor Competitive Strengths & Weaknesses
7.6 CSL Behring
  7.6.1 CSL Behring Details
  7.6.2 CSL Behring Major Business
  7.6.3 CSL Behring Recombinant Factor Products Product and Services
  7.6.4 CSL Behring Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 CSL Behring Recent Developments/Updates
  7.6.6 CSL Behring Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Details
  7.7.2 GlaxoSmithKline Major Business
  7.7.3 GlaxoSmithKline Recombinant Factor Products Product and Services
  7.7.4 GlaxoSmithKline Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 GlaxoSmithKline Recent Developments/Updates
  7.7.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.8 Grifol
  7.8.1 Grifol Details
  7.8.2 Grifol Major Business
  7.8.3 Grifol Recombinant Factor Products Product and Services
  7.8.4 Grifol Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 Grifol Recent Developments/Updates
  7.8.6 Grifol Competitive Strengths & Weaknesses
7.9 Eli Lilly
  7.9.1 Eli Lilly Details
  7.9.2 Eli Lilly Major Business
  7.9.3 Eli Lilly Recombinant Factor Products Product and Services
  7.9.4 Eli Lilly Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 Eli Lilly Recent Developments/Updates
  7.9.6 Eli Lilly Competitive Strengths & Weaknesses
7.10 Bayer
  7.10.1 Bayer Details
  7.10.2 Bayer Major Business
  7.10.3 Bayer Recombinant Factor Products Product and Services
  7.10.4 Bayer Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.10.5 Bayer Recent Developments/Updates
  7.10.6 Bayer Competitive Strengths & Weaknesses
7.11 Pfizer
  7.11.1 Pfizer Details
  7.11.2 Pfizer Major Business
  7.11.3 Pfizer Recombinant Factor Products Product and Services
  7.11.4 Pfizer Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024)
  7.11.5 Pfizer Recent Developments/Updates
  7.11.6 Pfizer Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Recombinant Factor Products Industry Chain
8.2 Recombinant Factor Products Upstream Analysis
8.3 Recombinant Factor Products Midstream Analysis
8.4 Recombinant Factor Products Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Recombinant Factor Products Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Recombinant Factor Products Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Recombinant Factor Products Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Recombinant Factor Products Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Recombinant Factor Products Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Recombinant Factor Products Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Recombinant Factor Products Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Recombinant Factor Products Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Recombinant Factor Products Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Recombinant Factor Products Players in 2023
Table 12. World Recombinant Factor Products Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Recombinant Factor Products Company Evaluation Quadrant
Table 14. Head Office of Key Recombinant Factor Products Player
Table 15. Recombinant Factor Products Market: Company Product Type Footprint
Table 16. Recombinant Factor Products Market: Company Product Application Footprint
Table 17. Recombinant Factor Products Mergers & Acquisitions Activity
Table 18. United States VS China Recombinant Factor Products Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Recombinant Factor Products Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Recombinant Factor Products Companies, Headquarters (States, Country)
Table 21. United States Based Companies Recombinant Factor Products Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Recombinant Factor Products Revenue Market Share (2019-2024)
Table 23. China Based Recombinant Factor Products Companies, Headquarters (Province, Country)
Table 24. China Based Companies Recombinant Factor Products Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Recombinant Factor Products Revenue Market Share (2019-2024)
Table 26. Rest of World Based Recombinant Factor Products Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Recombinant Factor Products Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Recombinant Factor Products Revenue Market Share (2019-2024)
Table 29. World Recombinant Factor Products Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Recombinant Factor Products Market Size by Type (2019-2024) & (USD Million)
Table 31. World Recombinant Factor Products Market Size by Type (2025-2030) & (USD Million)
Table 32. World Recombinant Factor Products Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Recombinant Factor Products Market Size by Application (2019-2024) & (USD Million)
Table 34. World Recombinant Factor Products Market Size by Application (2025-2030) & (USD Million)
Table 35. Amgen Basic Information, Area Served and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Recombinant Factor Products Product and Services
Table 38. Amgen Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Amgen Recent Developments/Updates
Table 40. Amgen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Recombinant Factor Products Product and Services
Table 44. Novartis Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Baxter Basic Information, Area Served and Competitors
Table 48. Baxter Major Business
Table 49. Baxter Recombinant Factor Products Product and Services
Table 50. Baxter Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Baxter Recent Developments/Updates
Table 52. Baxter Competitive Strengths & Weaknesses
Table 53. Britannia Basic Information, Area Served and Competitors
Table 54. Britannia Major Business
Table 55. Britannia Recombinant Factor Products Product and Services
Table 56. Britannia Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Britannia Recent Developments/Updates
Table 58. Britannia Competitive Strengths & Weaknesses
Table 59. Capricor Basic Information, Area Served and Competitors
Table 60. Capricor Major Business
Table 61. Capricor Recombinant Factor Products Product and Services
Table 62. Capricor Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Capricor Recent Developments/Updates
Table 64. Capricor Competitive Strengths & Weaknesses
Table 65. CSL Behring Basic Information, Area Served and Competitors
Table 66. CSL Behring Major Business
Table 67. CSL Behring Recombinant Factor Products Product and Services
Table 68. CSL Behring Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. CSL Behring Recent Developments/Updates
Table 70. CSL Behring Competitive Strengths & Weaknesses
Table 71. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 72. GlaxoSmithKline Major Business
Table 73. GlaxoSmithKline Recombinant Factor Products Product and Services
Table 74. GlaxoSmithKline Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. GlaxoSmithKline Recent Developments/Updates
Table 76. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 77. Grifol Basic Information, Area Served and Competitors
Table 78. Grifol Major Business
Table 79. Grifol Recombinant Factor Products Product and Services
Table 80. Grifol Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Grifol Recent Developments/Updates
Table 82. Grifol Competitive Strengths & Weaknesses
Table 83. Eli Lilly Basic Information, Area Served and Competitors
Table 84. Eli Lilly Major Business
Table 85. Eli Lilly Recombinant Factor Products Product and Services
Table 86. Eli Lilly Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Eli Lilly Recent Developments/Updates
Table 88. Eli Lilly Competitive Strengths & Weaknesses
Table 89. Bayer Basic Information, Area Served and Competitors
Table 90. Bayer Major Business
Table 91. Bayer Recombinant Factor Products Product and Services
Table 92. Bayer Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Bayer Recent Developments/Updates
Table 94. Pfizer Basic Information, Area Served and Competitors
Table 95. Pfizer Major Business
Table 96. Pfizer Recombinant Factor Products Product and Services
Table 97. Pfizer Recombinant Factor Products Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 98. Global Key Players of Recombinant Factor Products Upstream (Raw Materials)
Table 99. Recombinant Factor Products Typical Customers

LIST OF FIGURE

Figure 1. Recombinant Factor Products Picture
Figure 2. World Recombinant Factor Products Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant Factor Products Total Market Size (2019-2030) & (USD Million)
Figure 4. World Recombinant Factor Products Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Recombinant Factor Products Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Recombinant Factor Products Revenue (2019-2030) & (USD Million)
Figure 13. Recombinant Factor Products Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 16. World Recombinant Factor Products Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 18. China Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 23. India Recombinant Factor Products Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Recombinant Factor Products by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Recombinant Factor Products Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Recombinant Factor Products Markets in 2023
Figure 27. United States VS China: Recombinant Factor Products Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant Factor Products Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Recombinant Factor Products Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Recombinant Factor Products Market Size Market Share by Type in 2023
Figure 31. Clotting Factor I
Figure 32. Clotting Factor II
Figure 33. Clotting Factor III
Figure 34. Clotting Factor IV
Figure 35. Others
Figure 36. World Recombinant Factor Products Market Size Market Share by Type (2019-2030)
Figure 37. World Recombinant Factor Products Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 38. World Recombinant Factor Products Market Size Market Share by Application in 2023
Figure 39. Hospitals
Figure 40. Clinics
Figure 41. Recombinant Factor Products Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source